BRIEF published on 04/24/2025 at 16:07, 1 year 4 months ago Vanguard Discloses Interest in Primary Health Properties Takeover Code Vanguard Group Financial Disclosure Shareholding Primary Health Properties
BRIEF published on 04/24/2025 at 16:06, 1 year 4 months ago Vanguard Discloses Significant Holding in Assura plc Securities Disclosure Vanguard Group Shareholding Assura Plc
PRESS RELEASE published on 04/24/2025 at 16:05, 1 year 4 months ago Form 8.3 - The Vanguard Group, Inc.: Qualcomm Incorporated The Vanguard Group, Inc. discloses 10.52% interest in Qualcomm Incorporated. Alphawave IP Group plc also involved. Dealings and positions detailed Disclosure Vanguard Group Dealings Qualcomm Alphawave IP Group
BRIEF published on 04/24/2025 at 16:05, 1 year 4 months ago The Vanguard Group Discloses Position in Aviva plc Form 8.3 Takeover Code Vanguard Group Investment Disclosure Aviva Plc
PRESS RELEASE published on 04/24/2025 at 16:05, 1 year 4 months ago Form 8.3 - The Vanguard Group, Inc.: American Axle & Manufacturing Holdings, Inc. The Vanguard Group, Inc. discloses a 11.32% interest in American Axle & Manufacturing Holdings, Inc. with recent purchases of USD 0.01 common shares Disclosure The Vanguard Group Purchases Interests American Axle & Manufacturing Holdings
BRIEF published on 04/24/2025 at 16:04, 1 year 4 months ago The Vanguard Group Discloses Interests in Alphawave IP Group Takeover Code Vanguard Group Stake Disclosure Share Transactions Alphawave IP
PRESS RELEASE published on 04/24/2025 at 16:04, 1 year 4 months ago Form 8.3 - The Vanguard Group, Inc.: Dalata Hotel Group plc The Vanguard Group, Inc. discloses a 3.33% stake in Dalata Hotel Group plc in an opening position disclosure under Irish takeover rules Opening Position Disclosure Vanguard Group Dalata Hotel Group Irish Takeover Rules 3.33% Stake
BRIEF published on 04/24/2025 at 16:03, 1 year 4 months ago The Vanguard Group Discloses Position in Dowlais Group plc Form 8.3 The Vanguard Group Takeover Code Shareholding Disclosure Dowlais Group Plc
PRESS RELEASE published on 04/24/2025 at 16:03, 1 year 4 months ago Form 8.3 - The Vanguard Group, Inc.: Greencore Group plc The Vanguard Group, Inc. discloses a 5.37% stake in Greencore Group plc. Additional disclosures include dealings with Bakkavor Group plc The Vanguard Group Stake Disclosure Dealings Disclosure Greencore Group Plc Bakkavor Group Plc
BRIEF published on 04/24/2025 at 16:03, 1 year 4 months ago The Vanguard Group Discloses Stake in Bakkavor Group Form 8.3 The Vanguard Group Stake Disclosure Shares Transactions Bakkavor Group
Published on 09/12/2026 at 02:35, 1 hour 54 minutes ago Gamma Resources Announces Extension of Private Placement Closing Date
Published on 09/11/2026 at 23:00, 5 hours 29 minutes ago Rio Grande Resources Engages Machai Capital for Investor Outreach
Published on 09/11/2026 at 22:05, 6 hours 24 minutes ago Usha Resources Announces Leadership Transition
Published on 09/11/2026 at 21:25, 7 hours 4 minutes ago Algo Grande Copper Intersects 30.23 Metres Grading 1.5% CuEq, including 3.55 Metres at 9.4% CuEq and 1.2-Metre Interval at 15.8% CuEq, 100 Metres Vertical Step-Out from Historical Intersects
Published on 09/11/2026 at 17:00, 11 hours 29 minutes ago Critical Elements Selected for Canada Investment Summit Prospectus, Showcasing Project to Leading Global Investors
Published on 09/11/2026 at 22:15, 6 hours 14 minutes ago Amrize Appoints Mario Gross as President of Building Envelope
Published on 09/11/2026 at 22:10, 6 hours 19 minutes ago Quantinuum to Participate in the Piper Sandler 5th Annual Growth Frontiers Conference
Published on 09/11/2026 at 19:44, 8 hours 44 minutes ago DocMorris announces final conversion price and issue size of its New Convertible Bonds due 2031
Published on 09/11/2026 at 18:15, 10 hours 14 minutes ago CGTN: How BRICS creates new opportunities for Global South development
Published on 09/11/2026 at 07:00, 21 hours 29 minutes ago Transparency notification by Baltisse Group
Published on 09/11/2026 at 07:00, 21 hours 29 minutes ago BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY
Published on 09/10/2026 at 19:30, 1 day 8 hours ago Availability of the 2026 Interim Financial Report
